Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘NASDAQ:ARDX’

Here’s What Hedge Funds Think About Ardelyx Inc (ARDX)

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.......(read more)
Kris Jenner - Rock Springs Capital

Is Ardelyx Inc (ARDX) A Good Stock To Buy?

Hedge funds are known to underperform the bull markets but that’s not because they are terrible at stock picking. Hedge funds underperform because......(read more)
James Flynn Deerfield Management

Ardelyx Inc (ARDX): Are Hedge Funds Right About This Stock?

Is Ardelyx Inc (NASDAQ:ARDX) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research......(read more)
biotech research company, bio-technology companies

13G Filing: Rock Springs Capital Management and Ardelyx Inc. (ARDX)

Ardelyx Inc. (NASDAQ:ARDX): Kris Jenner, Gordon Bussard and Graham Mcphail’s Rock Springs Capital Management filed an amended 13D. You can check......(read more)
biotech research company, bio-technology companies

13G Filing: James E. Flynn and Ardelyx Inc. (ARDX)

Ardelyx Inc (NASDAQ:ARDX): James E. Flynn’s Deerfield Management filed an amended 13D. You can check out Deerfield Management’s latest holdings......(read more)

Here’s What The Latest Ardelyx Inc (ARDX) Data Means For The Company Going Forward

Ardelyx Inc (NASDAQ:ARDX) just put out data from a phase III study in patients with end stage renal disease, and the company is running up on the back......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Is Ardelyx Inc (ARDX) A Good Stock To Buy Right Now?

Billionaire hedge fund managers such as Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down......(read more)

RA Capital’s Top Q2 Performers; Predicts Big Things Ahead for Pharma Stocks

RA Capital Management LLC is a crossover fund manager that invests in public and private healthcare and life science companies developing drugs, medical......(read more)
BPMC

Ardelyx (ARDX): RA Capital Management Boosts Stake to 7.7%

Peter Kolchinsky‘s RA Capital Management has stepped up its interest in Ardelyx Inc. (NASDAQ:ARDX). As reported in a recent filing with the Securities......(read more)

Massive Insider Buying Witnessed at 3 Companies, Including This Fresh Acquisition Target

High-ranking executives have more knowledge and insight concerning the state of their companies, the market conditions within their industries, and possible......(read more)

Here’s Why Investors Are Piling Into These Five Stocks

With the VIX fear index retreating by 6.6% today and volatility calming down a bit, investors are snapping up NGL Energy Partners LP (NYSE:NGL), Boyd......(read more)
Delta Airlines DAL Monte Carlo airplane

Delta Air Lines Inc. (DAL), Ardelyx Inc. (ARDX) & Exa Corp (EXA) Witnessing Insider Buying Activity

Unquestionably, most companies’ officers and directors have more up-to-date insights about their companies’ ongoing challenges, future prospects and......(read more)
Highest Paid Medical Technicians in America

Is Ardelyx Inc (ARDX) A Good Stock To Buy?

The market has been volatile as the Federal Reserve winds down its easy money policies. Small cap stocks have been hit hard as a result, as the Russell......(read more)

Ardelyx Inc (ARDX): RA Capital Management Discloses 7.3% Passive Stake

RA Capital Management, led by Peter Kolchinsky, has opened a new position in clinical-stage biopharmaceutical company Ardelyx Inc (NASDAQ:ARDX). A new......(read more)